Is Humana Inc (HUM) overvalued? · P/E 39, rev $117.76B
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
This page asks whether Humana Inc (HUM) looks expensive on cached numbers — not a short thesis.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next HUM 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the HUM stock page for the full model, not this heading.
Not investment advice.